Captor Therapeutics ® Investor Relations

      Investor Relations

      Admission and introduction to exchange trading of series K ordinary bearer shares

      Publication date: 2022-06-29
      Number: RB EBI 24/2022

      Current Report No. 24/2022

      Date of preparation: 29 June 2022

      Subject: Admission and introduction to exchange trading of series K ordinary bearer shares

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company") became aware of the adoption by the Management Board of Giełda Papierów Wartościowych w Warszawie S.A. of resolution no. 651/2022 dated 29 June 2022 on introduction, as of 1 July 2022, to exchange trading on the primary market of 30,738 series K ordinary bearer shares of the Company, with a nominal value of PLN 0.10 each, provided that on 1 July 2022 Krajowy Depozyt Papierów Wartościowych S.A. registers such shares and marks them with the following code: ISIN PLCPTRT00014.

      Resolution enters into force as of the date of adoption thereof.

       

      Detailed legal basis:

      §17(1)(2 and 4) of the RMF on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state